New Delhi- The Medical Counselling Committee (MCC) has announced the addition of 135 postgraduate medical seats (MD/MS) to the Round-2 seat matrix of the National Eligibility and Entrance Test-Postgraduate (NEET…
A recent systematic review and meta-analysis concluded that there is no significant difference in most safety outcomes between a fasting and a non-fasting strategy prior to percutaneous cardiac procedures with…
New Delhi: Inspections of the trauma building of Delhi's Ram Manohar Lohia (RML) hospital revealed a series of critical violations, including non-functional fire safety systems, missing fire check doors, damaged hydrants, and inadequate access…
Mumbai: Piramal Pharma has announced that the company has received four observations from the U.S. Food and Drug Administration (USFDA) for Lexington (Kentucky, USA) facility. The general Good Manufacturing Practices (GMP)…
Mumbai: Indoco Remedies Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredients (API) manufacturing facility located at…
Mumbai: Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute announced that its Mumbai facility has been awarded the Certificate of Distinction for its Healthcare Sustainability Program from Joint Commission International (JCI)…
New Delhi: Through a notice, the All India Institute of Medical Sciences (AIIMS), New Delhi, has outlined the Guidelines and Principles for the creation of a 200-Point Roster to be used for…
Udaipur: The prestigious Samvedna Women Award has been bestowed upon Dr Paristish Kamdar of the Department of Psychiatry, Geetanjali Medical College & Hospital (GMCH), Udaipur, at the 26th Annual National…
Hyderabad: In an big milestone, Dr Raghu Ram, Founding Director at KIMS-USHALAKSHMI Centre for Breast Diseases, has become the first and only surgeon from India to be elected onto to…
London: GSK plc has announced that its B7-H3-targeted antibody-drug conjugate GSK'227, now referred to by its International Nonproprietary Name, risvutatug rezetecan, has received Orphan Drug Designation (ODD) from the US…